vatalanib has been researched along with cgp 53716 in 1 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (cgp 53716) | Trials (cgp 53716) | Recent Studies (post-2010) (cgp 53716) |
---|---|---|---|---|---|
276 | 42 | 98 | 15 | 0 | 2 |
Protein | Taxonomy | vatalanib (IC50) | cgp 53716 (IC50) |
---|---|---|---|
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.3981 | |
Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 0.1 | |
Breakpoint cluster region protein | Homo sapiens (human) | 0.3981 | |
Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campochiaro, PA; Kwak, N; Okamoto, N; Wood, JM | 1 |
1 other study(ies) available for vatalanib and cgp 53716
Article | Year |
---|---|
VEGF is major stimulator in model of choroidal neovascularization.
Topics: Animals; Choroidal Neovascularization; Endothelial Growth Factors; Enzyme Inhibitors; Genistein; Lymphokines; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Phthalazines; Platelet-Derived Growth Factor; Protein Kinase C; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |